Arteriosclerosis
Conditions
Interventions
6 months
Once a day, the CTP tablet 16 tablets orally taken with a glass of water or lukewarm water cup at dinner (can be any of the pre-meal, after a meal).
Sponsors
Saiseikai Matsuyama Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. This study to understand, there is the ability to comply with it who 2. Prior to participation in the study, those who consent by the document can be obtained 3. Hyperlipidemia, or hypertension, or who have been diagnosed with both its
Exclusion criteria
Exclusion criteria: 1.Those who study doctor was ineligible as an object of the present study 2. Those of type 1 or type 2 diabetes 3. A person suspected of cerebral infarction with paralysis Four. Acute coronary syndrome, unstable angina, acute myocardial infarction, a person with a history of acute cerebral infarction and transient ischemic attack Five. Patients with cancer 6. Hypothyroidism, the person suspected of Graves' disease 7. A person suspected of liver disease, including hepatitis virus persistent infection 8. Persons with renal disease severe 9. A person who has a liver disorder of severe 10. Who during pregnancy and lactation 11. Patient in hospital 12. It is under ingestion other health supplements, functional foods, those who can not stop eating during the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) blood lipid 2) ABI inspection 3) PWV inspection 4) carotid artery echo 5) liver function tests | — |
Countries
Japan
Contacts
Public ContactYoshiharu Shimizu
Saiseikai Matsuyama Hospital Clinical trial management office
Outcome results
None listed